516 reports of this reaction
1.4% of all PHENYTOIN reports
#19 most reported adverse reaction
ATAXIA is the #19 most commonly reported adverse reaction for PHENYTOIN, manufactured by Viatris Specialty LLC. There are 516 FDA adverse event reports linking PHENYTOIN to ATAXIA. This represents approximately 1.4% of all 36,996 adverse event reports for this drug.
Patients taking PHENYTOIN who experience ataxia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ATAXIA is a less commonly reported adverse event for PHENYTOIN, but still significant enough to appear in the safety profile.
In addition to ataxia, the following adverse reactions have been reported for PHENYTOIN:
The following drugs have also been linked to ataxia in FDA adverse event reports:
ATAXIA has been reported as an adverse event in 516 FDA reports for PHENYTOIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
ATAXIA accounts for approximately 1.4% of all adverse event reports for PHENYTOIN, making it a notable side effect.
If you experience ataxia while taking PHENYTOIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.